HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alejandro de la Sierra Selected Research

eprosartan (Teveten)

6/2009Antihypertensive treatment and stroke prevention: are angiotensin receptor blockers superior to other antihypertensive agents?
11/2007Introduction: The pharmacological profile of eprosartan--implications for cerebrovascular and cardiovascular risk reduction.
1/2006Effects of eprosartan on target organ protection.
12/2004Effect of eprosartan on pulse pressure and blood pressure components in patients with isolated systolic hypertension.
10/2004The effect of treatment with eprosartan on pulse pressure: factors predicting response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alejandro de la Sierra Research Topics

Disease

30Hypertension (High Blood Pressure)
09/2018 - 01/2002
12Cardiovascular Diseases (Cardiovascular Disease)
04/2018 - 12/2004
9Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
07/2015 - 06/2002
6Stroke (Strokes)
06/2009 - 02/2002
5Abdominal Obesity
01/2018 - 07/2007
5Dyslipidemias (Dyslipidemia)
07/2015 - 07/2007
5Essential Hypertension
10/2004 - 01/2002
4Obesity
04/2018 - 07/2002
4Insulin Resistance
01/2013 - 07/2002
4Type 2 Diabetes Mellitus (MODY)
09/2011 - 11/2007
3Proteinuria
09/2011 - 06/2002
3Heart Failure
06/2009 - 09/2004
3Metabolic Syndrome (Dysmetabolic Syndrome X)
04/2008 - 07/2007
2Hypotension (Low Blood Pressure)
01/2020 - 05/2017
2Coronary Disease (Coronary Heart Disease)
01/2020 - 05/2017
2Overweight
01/2018 - 04/2008
2Hypertriglyceridemia
07/2015 - 06/2009
2Diabetic Nephropathies (Diabetic Nephropathy)
09/2011 - 06/2009
2Myocardial Infarction
06/2009 - 01/2009
2Atherosclerosis
06/2009 - 09/2005
2Cough
06/2009 - 01/2002
2Inflammation (Inflammations)
01/2006 - 01/2006
1Urinary Tract Infections (Urinary Tract Infection)
01/2018
1Albuminuria
01/2018
1Heart Diseases (Heart Disease)
05/2017
1Atrial Fibrillation
06/2016
1White Coat Hypertension
01/2015
1Hypertrophy
03/2013
1Ventricular Remodeling
09/2011
1Infarction (Infarctions)
09/2011
1Chronic Renal Insufficiency
09/2011
1Left Ventricular Dysfunction
06/2009
1Angioedema
06/2009
1Diabetes Mellitus
01/2009
1Vascular Diseases (Vascular Disease)
01/2009
1Chronic Cough
11/2007
1Chronic Obstructive Pulmonary Disease (COPD)
05/2005
1Isolated Systolic Hypertension
12/2004

Drug/Important Bio-Agent (IBA)

19Antihypertensive Agents (Antihypertensives)IBA
01/2020 - 01/2002
7Angiotensin Receptor AntagonistsIBA
03/2013 - 01/2006
5Triglycerides (Triacylglycerol)IBA
01/2018 - 07/2007
5HDL CholesterolIBA
07/2015 - 07/2007
5Hydrochlorothiazide (Esidrix)FDA LinkGeneric
10/2014 - 06/2002
5AlbuminsIBA
09/2014 - 06/2009
5Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
12/2011 - 11/2007
5eprosartan (Teveten)FDA Link
06/2009 - 10/2004
4Glucose (Dextrose)FDA LinkGeneric
04/2017 - 07/2002
4olmesartanIBA
10/2014 - 03/2013
3LipidsIBA
04/2017 - 04/2008
3Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
09/2011 - 02/2002
3DiureticsIBA
05/2011 - 01/2009
2Spironolactone (Aldactone)FDA LinkGeneric
01/2018 - 01/2017
2Diltiazem (Cardizem)FDA LinkGeneric
06/2016 - 06/2016
2Calcium Channel Blockers (Blockers, Calcium Channel)IBA
06/2016 - 01/2006
2Amlodipine (Norvasc)FDA LinkGeneric
10/2014 - 05/2014
2NitrendipineIBA
06/2009 - 01/2006
2LDL CholesterolIBA
07/2007 - 12/2004
2Angiotensin IIIBA
01/2006 - 09/2005
2IrbesartanFDA LinkGeneric
11/2003 - 01/2002
2SaltsIBA
04/2003 - 01/2002
1CholesterolIBA
07/2013
1Pharmaceutical PreparationsIBA
03/2013
1Drug CombinationsIBA
05/2012
1aliskirenFDA Link
09/2011
1CalciumIBA
06/2009
1Angiotensin Receptors (Angiotensin II Receptor)IBA
06/2009
1Telmisartan (Micardis)FDA Link
06/2009
1perindopril drug combination indapamideIBA
01/2009
1IndapamideFDA LinkGeneric
01/2009
1PerindoprilFDA LinkGeneric
01/2009
1Gliclazide (Diamicron)IBA
01/2009
1C-Reactive ProteinIBA
01/2008
1Angiotensin II Type 1 Receptor BlockersIBA
11/2007
1Carbon MonoxideIBA
11/2007
1Neuroprotective AgentsIBA
01/2006
1LDL Lipoproteins (beta Lipoproteins)IBA
12/2004
1G-protein beta3 subunitIBA
07/2002
1Insulin (Novolin)FDA Link
07/2002
1CreatinineIBA
06/2002
1Proteins (Proteins, Gene)FDA Link
06/2002
1Losartan (Cozaar)FDA LinkGeneric
06/2002
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2002
1EnalaprilFDA LinkGeneric
01/2002

Therapy/Procedure

16Therapeutics
09/2018 - 11/2003
2Denervation
01/2018 - 01/2017
1Catheters
01/2018
1Length of Stay
05/2005
1Aftercare (After-Treatment)
06/2002